business

Spyre Therapeutics CMO Sheldon Sloan sells $624,975 in stock

Investing.com · Jun 4, 2026, 1:44 AM · Also reported by 1 other source

Read full story on Investing.com → More top stories

Also covered by

Yahoo Finance CRISPR Therapeutics Stock Is Absurdly Cheap -- Here's Why Analysts See 437% Upside Potential

Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

Spyre Therapeutics CMO Sheldon Sloan sells $624,975 in stock

Also covered by

More in business